Atlas Trials

Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially

Clinical trial NCT04563377 · COMPLETED

Trial details

NCT number
NCT04563377
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Healthy
Start date
2021-11-01
Primary completion
2022-08-16
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.